Articles
Partnership to further develop anticancer formulation
The University of Wollongong (UOW) has licensed the commercialisation rights to a novel drug formulation for the treatment of metastatic colorectal cancer (mCRC) to a local biotech company - FivePhusion. [ + ]
Driving innovation
AusBiotech welcomes the federal government’s Plan for Australian Jobs, which will aid innovative companies and help support the biotechnology sector. [ + ]
pSivida partner to resubmit Iluvien NDA this month
pSivida (ASX:PVA) has said partner Alimera plans to resubmit Iluvien for US approval in March and that it will receive a $23.9 million milestone payment if the NDA is accepted. [ + ]
Organ preservation device is not chopped liver
In a world first, a donated human liver has been ‘kept alive’ outside a human being and then successfully transplanted into a patient in need of a new liver. The procedure has been performed on two patients on the liver transplant waiting list and both are making excellent recoveries. [ + ]
Viralytics CEO hails cancer virotherapy milestone
Viralytics (ASX:VLA) CEO Dr Malcolm McColl has called the news that Amgen met its goal with an oncolytic virus trial a “milestone event for the field.” [ + ]
Who’s who in biotech business development gather in Adelaide
The Business Development Workshop and Forum has kicked off in Adelaide, with delegates keen to understand the changing landscape of licensing deal collaborations and what it means for business development in biotechnology companies. [ + ]
Biotron HIV drug targets reservoir cells
Preliminary results of a phase Ib/IIa trial of Biotron’s BIT225 treatment candidate show it can target HIV in cells which mature into ongoing reservoirs for the virus. [ + ]
Lazarus Project to bring extinct frog back to life
The genome of an extinct Australian frog has been revived and reactivated by a team of scientists using sophisticated cloning technology to implant a ‘dead’ cell nucleus into a fresh egg from another frog species. The effort has been dubbed ‘the Lazarus Project’. [ + ]
Biolife signs cancer vaccine manufacturing deal
Biolife Science has signed on Pevion Biotech to manufacture its HER-Vaxx anticancer vaccine in preparation for phase II trials in gastric cancer. [ + ]
INTERPOL and pharmaceutical industry launch global initiative to combat fake medicines
Combating the global scourge of fake medicines that threatens the health of millions of people is the focus of a landmark agreement between INTERPOL and 29 of the world’s largest pharmaceutical companies. [ + ]
It may be a Higgs boson but is it the Standard Model?
It looks like the particle discovered at the Large Hadron Collider last year is an elusive Higgs boson but whether this is the Higgs boson of the Standard Model of particle physics, or possibly the lightest of several bosons predicted in some theories that go beyond the Standard Model, has yet to be established. [ + ]
Starpharma signs new agrochemical tie-up
Starpharma (ASX:SPL) has signed a crop protection collaboration covering the use of its dendrimer nanotechnology platform technology by Makhteshim Agan. [ + ]
Cooperative research continues
The 15th selection round for cooperative research centres will see the government spend $70 million on three new centres. [ + ]
Got worms? Turn your iPhone into a microscope and check
Scientists working in rural Tanzania have used a simple US$8 glass lens, a strip of double-sided tape and a cheap flashlight to convert an Apple iPhone into a field microscope that can successfully detect intestinal worm infections in children. [ + ]
Robots play role in dementia treatment
Proving the benefits and cost-effectiveness of animal robots in the treatment of dementia is the focus of a Griffith research study. [ + ]